All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

A Study to Evaluate Adverse Events and Change in Disease Activity of Mirvetuximab Soravtansine-gynx in Adults With Folate Receptor-Alpha Positive, Platinum-Resistant Ovarian Cancer in a Real-World Setting

2d agoen
Read on clinicaltrials.gov

From the article

Conditions : Folate Receptor-Alpha Positive Platinum-Resistant High-Grade Serous Epithelial Ovarian Cancer; Folate Receptor-Alpha Positive Platinum-Resistant Fallopian Tube Cancer; Folate Receptor-Alpha Positive Platinum-Resistant Primary Peritoneal Cancer Sponsors : AbbVie Not yet recruiting
Continue reading on clinicaltrials.gov

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.